Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05468359
Status:
RECRUITING
Last Update Posted:
2023-12-22
First Post:
2022-06-13
Brief Title:
Safety and Efficacy of Cyclophosphamide Sorafenib Bevacizumab and Atezolizumab in Pediatric Solid Tumor Patients
Sponsor:
St Jude Childrens Research Hospital
Organization:
St Jude Childrens Research Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2032-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2037-06
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-13
First Submit QC Date:
July 19 2022
Study First Post Date:
2022-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-21
Last Update Post Date:
2023-12-22
Last Update Post Date Type:
ACTUAL